谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience

J. C. Singh,S. Sugarman,L. Jones,C. Boafo,S. Patil,S. Schweber, A. Yu,D. Argolo,S. Modi,N. Iyengar,L. Smyth,L. Norton,J. Baselga,C. Hudis,C. Dang

The Oncologist（2017）

引用 30|浏览30
关键词
HER2-positive,Neoadjuvant,Breast cancer,Pertuzumab,Anthracycline
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要